New Product Briefs
This article was originally published in The Gray Sheet
Executive Summary
FDA approves St. Jude's Brio deep brain stimulator for Parkinson's and essential tremor. The agency also approves Aesculap's activL artificial disc and said Cerapedics' i-Factor bone graft review will proceed without an advisory panel.
You may also be interested in...
Cervical Spine Bone Graft Gains FDA Go-Ahead
Cerapedics' i-Factor peptide-enhanced bone graft will be used to treat degenerative cervical disc disease, the first bone graft product PMA-approved for that indication, the company says.
St. Jude Reveals Path For AF Ablation Catheter: 3-Year Study Begins Soon
St. Jude Medical will begin enrollment by July for a pivotal study of its Cool Path Duo/Safire BLU Duo irrigated radiofrequency energy-based catheter ablation system for treatment of atrial fibrillation, the firm said during its Feb. 5 annual investor day
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.